221 results on '"Eming R"'
Search Results
2. Therapie des bullösen Pemphigoids
3. Einsatz B-Zell-depletierender Antikörper bei Hauterkrankungen
4. 043 A novel tool to analyse the pathogenic impact of IgG binding to extracellular domain 5 of Desmoglein 3
5. 065 Evaluating pathogenicity of skin autoantibodies in hereditary epidermolysis bullosa hints towards predisposition of autoimmunity
6. Treating Autoimmune Bullous Skin Disorders with Biologics
7. Paraneoplastic pemphigus with anti‐BP180 autoantibodies and Castleman disease
8. Pemphigus: Modellerkrankung für zielgerichtete Therapien
9. 009 Human desmocollin 3-specific IgG antibodies are pathogenic in a humanized HLA-class II transgenic mouse model of pemphigus
10. Für die Praxis: Diagnostik und Therapie von Pemphigus: S06/01
11. Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients
12. Einfluss von Fumarsäureestern auf T-Zellsubpopulationen bei Patienten mit Psoriasis
13. Ca 2+ signalling is critical for autoantibody‐induced blistering of human epidermis in pemphigus*
14. Arbeiten mit Beton: Grad-IIb-Laugenverätzung der unteren Extremität
15. Autoinflammatorische Erkrankungen als Ursache von Wundheilungsstörungen
16. The expanding spectrum of IgA pemphigus: a case report and review of the literature
17. Einsatz B-Zell-depletierender Antikörper bei Hauterkrankungen
18. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system
19. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
20. Novel dendritic cell-based in vitro system for the detection of autoreactive CD4+ T cells in pemphigus: P200
21. Pemphigus vulgaris in Egyptians is associated with the HLA Class II alleles DRB1*04:02:01, *14:56 and *08:04:01.: P138
22. A Humanized HLA-class II transgenic mouse model for the analysis of desmocollin 3-specific T - and B cell responses in pemphigus: P117 (V15)
23. Plasmacytoid dendritic cells in pemphigus vulgaris: P079
24. Einsatz von Rituximab in der Behandlung des Pemphigus: Ergebnisse einer multizentrischen Beobachtungsstudie im Rahmen des Deutschen Registers für Autoimmunerkrankungen: FV07/01
25. Die Kombinationstherapie aus Immunadsorption und Rituximab führt bei Patienten mit schwerem Pemphigus vulgaris zu schneller und anhaltender klinischer Remission: FV07/03
26. Immunserologische Diagnostik bullöser Autoimmundermatosen: WS06/03
27. Clinical Response of Severe Mechanobullous Epidermolysis Bullosa Acquisita to Combined Treatment with Immunoadsorption and Rituximab (anti-CD20 monoclonal antibodies)
28. Detection of Low Avidity Desmoglein 3-Reactive T Cells in Pemphigus Vulgaris using HLA-DRβ1*0402-Tetramers
29. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS)
30. Treatment with Rituximab (anti-CD20) Affects Both Autoreactive T and B Lymphocytes in Pemphigus Vulgaris
31. Ca2+ signalling is critical for autoantibody‐induced blistering of human epidermis in pemphigus*.
32. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay
33. 080 Modulation of the T helper and T follicular helper cell distribution in pemphigus patients by B cell-depleting therapy
34. 079 Detection and monitoring of autoreactive T cell responses against desmoglein 1 and 3 in patients with pemphigus
35. 031 Development of a mouse model of Pemphigus Vulgaris as a tool to evaluate nanoparticle induced antigen-specific tolerance
36. Successful treatment of cheilitis granulomatosa with lenalidomide
37. Diagnosis of anti‐laminin γ‐1 pemphigoid by immunoblot analysis
38. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis
39. 038 Therapeutic efficacy of IL-17 blockade identifies lichen planus as a Th17-driven skin disorder
40. 484 Lichen planus pemphigoides is a chimera of lichen planus and bullous pemphigoid
41. Diagnosis of anti‐laminin γ‐1 pemphigoid by immunoblot analysis.
42. 271 Oral and cutaneous lichen planus exhibit two different T cell antigenic specificities
43. European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology
44. Pemphigus
45. Treating Autoimmune Bullous Skin Disorders with Biologics
46. The expanding spectrum ofIgApemphigus: a case report and review of the literature
47. Diagnostik bullöser Autoimmundermatosen
48. Arbeiten mit Beton
49. Detection of IgG and IgE reactivity to BP180 using the ISAC®microarray system
50. Treating Autoimmune Bullous Skin Disorders with Biologics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.